UiPath (PATH) Financials

$16.45 +1.01 (+6.56%)

Closing price 03:59 PM Eastern

Extended Trading

$16.52 +0.06 (+0.38%)

As of 07:13 PM Eastern

Annual Income Statements for UiPath

This table shows UiPath's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-520	-92	-526	-328	-90	-74
Consolidated Net Income / (Loss)	-520	-92	-526	-328	-90	-74
Net Income / (Loss) Continuing Operations	-520	-92	-526	-328	-90	-74
Total Pre-Tax Income	-517	-95	-511	-318	-76	-78
Total Operating Income	-517	-110	-501	-348	-165	-163
Total Gross Profit	277	542	723	879	1,112	1,183
Total Revenue	336	608	892	1,059	1,308	1,430
Operating Revenue	336	608	892	1,059	1,308	1,430
Total Cost of Revenue	59	66	169	180	196	247
Operating Cost of Revenue	59	66	169	180	196	247
Total Operating Expenses	794	652	1,224	1,227	1,277	1,345
Selling, General & Admin Expense	180	162	250	240	232	226
Marketing Expense	483	380	698	702	713	738
Research & Development Expense	131	110	277	286	332	381
Total Other Income / (Expense), net	0.14	16	-9.94	31	89	84
Interest & Investment Income	6.74	1.15	3.55	28	57	49
Other Income / (Expense), net	-6.60	15	-13	2.77	32	35
Income Tax Expense	2.79	-2.27	15	11	14	-4.41
Basic Earnings per Share	($3.41)	($0.55)	($1.16)	($0.60)	($0.16)	($0.13)
Weighted Average Basic Shares Outstanding	152.38M	168.26M	454.63M	548.02M	563.86M	559.93M
Diluted Earnings per Share	($3.41)	($0.55)	($1.16)	($0.60)	($0.16)	($0.13)
Weighted Average Diluted Shares Outstanding	152.38M	168.26M	454.63M	548.02M	563.86M	559.93M
Weighted Average Basic & Diluted Shares Outstanding	-	-	542.09M	557.42M	569.01M	551.49M

This table shows UiPath's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-120	-58	-28	-32	-60	-32	34	-29	-86	-11	52
Consolidated Net Income / (Loss)	-120	-58	-28	-32	-60	-32	34	-29	-86	-11	52
Net Income / (Loss) Continuing Operations	-120	-58	-28	-32	-60	-32	34	-29	-86	-11	52
Total Pre-Tax Income	-116	-57	-27	-28	-57	-28	37	-25	-82	-25	55
Total Operating Income	-120	-67	-45	-46	-78	-56	15	-49	-103	-43	34
Total Gross Profit	198	220	261	246	238	276	352	280	253	291	359
Total Revenue	242	263	309	290	287	326	405	335	316	355	424
Operating Revenue	242	263	309	290	287	326	405	335	316	355	424
Total Cost of Revenue	45	43	48	44	49	50	53	55	63	64	65
Operating Cost of Revenue	45	43	48	44	49	50	53	55	63	64	65
Total Operating Expenses	318	287	306	292	316	332	337	329	356	334	326
Selling, General & Admin Expense	68	63	50	57	60	56	59	64	64	50	49
Marketing Expense	182	156	174	160	170	191	192	180	194	187	177
Research & Development Expense	68	67	82	75	87	85	86	86	98	97	100
Total Other Income / (Expense), net	3.91	10	18	18	21	28	22	25	21	18	21
Interest & Investment Income	4.51	9.56	13	14	14	14	15	14	13	10	12
Other Income / (Expense), net	-0.60	0.89	5.29	4.29	7.47	14	6.28	11	7.71	7.81	8.85
Income Tax Expense	4.09	1.18	0.73	3.63	3.83	3.93	2.68	3.78	3.83	-15	2.83
Basic Earnings per Share	($0.22)	($0.10)	($0.05)	($0.06)	($0.11)	($0.06)	$0.07	($0.05)	($0.15)	($0.02)	$0.09
Weighted Average Basic Shares Outstanding	546.06M	550.16M	548.02M	557.88M	562.88M	567.04M	563.86M	569.93M	568.04M	551.04M	559.93M
Diluted Earnings per Share	($0.22)	($0.10)	($0.05)	($0.06)	($0.11)	($0.06)	$0.07	($0.05)	($0.15)	($0.02)	$0.09
Weighted Average Diluted Shares Outstanding	546.06M	550.16M	548.02M	557.88M	562.88M	567.04M	563.86M	569.93M	568.04M	551.04M	559.93M
Weighted Average Basic & Diluted Shares Outstanding	549.61M	552.84M	557.42M	561.16M	566.74M	566.08M	569.01M	572.78M	549.96M	549.60M	551.49M

This table details how cash moves in and out of UiPath's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Change in Cash & Equivalents	62	137	1,398	-367	-340	-182
Net Cash From Operating Activities	-359	29	-55	-9.98	299	321
Net Cash From Continuing Operating Activities	-359	29	-55	-9.98	299	321
Net Income / (Loss) Continuing Operations	-520	-92	-526	-328	-90	-74
Consolidated Net Income / (Loss)	-520	-92	-526	-328	-90	-74
Depreciation Expense	8.67	12	15	19	23	17
Amortization Expense	37	49	41	58	60	60
Non-Cash Adjustments To Reconcile Net Income	130	56	474	387	344	374
Changes in Operating Assets and Liabilities, net	-15	4.72	-59	-146	-38	-58
Net Cash From Investing Activities	-40	-126	-35	-289	-440	-46
Net Cash From Continuing Investing Activities	-40	-126	-35	-289	-440	-46
Purchase of Property, Plant & Equipment	-21	-3.19	-12	-24	-7.34	-15
Acquisitions	-19	-20	-5.50	-30	0.00	0.00
Purchase of Investments	0.00	-103	-213	-388	-1,486	-1,506
Sale and/or Maturity of Investments	0.00	0.00	197	151	1,051	1,476
Other Investing Activities, net	-	0.00	-2.73	1.20	2.75	0.00
Net Cash From Financing Activities	458	250	1,470	-61	-197	-451
Net Cash From Continuing Financing Activities	458	250	1,470	-61	-197	-451
Repayment of Debt	0.00	-79	0.00	0.00	-5.86	-5.57
Repurchase of Preferred Equity	-0.59	-0.32	-0.16	-1.49	0.00	0.00
Repurchase of Common Equity	-129	-0.73	-3.73	0.00	-103	-391
Issuance of Common Equity	0.00	0.00	711	15	18	16
Other Financing Activities, net	3.60	26	12	-74	-106	-70
Effect of Exchange Rate Changes	3.19	-17	18	-6.81	-2.62	-7.03
Cash Interest Paid	0.10	1.71	0.69	0.65	0.56	0.31
Cash Income Taxes Paid	3.53	4.51	8.45	21	11	17

This table details how cash moves in and out of UiPath's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Net Change in Cash & Equivalents	-72	-156	-49	-91	-217	-91	59	85	-207	-166	106
Net Cash From Operating Activities	-24	-27	94	67	44	42	146	100	46	28	146
Net Cash From Continuing Operating Activities	-24	-27	94	67	44	42	146	100	46	28	146
Net Income / (Loss) Continuing Operations	-120	-58	-28	-32	-60	-32	34	-29	-86	-11	52
Consolidated Net Income / (Loss)	-120	-58	-28	-32	-60	-32	34	-29	-86	-11	52
Depreciation Expense	4.03	4.93	5.73	5.62	5.54	5.40	6.04	4.90	4.58	4.53	3.22
Amortization Expense	13	20	11	9.98	11	13	27	13	8.19	16	24
Non-Cash Adjustments To Reconcile Net Income	83	81	138	91	91	96	67	83	87	87	118
Changes in Operating Assets and Liabilities, net	-3.36	-75	-33	-7.02	-2.37	-40	12	28	33	-68	-51
Net Cash From Investing Activities	-29	-118	-126	-136	-235	-60	-8.64	36	-42	-23	-17
Net Cash From Continuing Investing Activities	-29	-118	-126	-136	-235	-60	-8.64	36	-42	-23	-17
Purchase of Property, Plant & Equipment	-6.61	-5.32	-2.20	-1.87	-1.01	-0.68	-3.78	-1.24	-1.42	-4.88	-7.39
Purchase of Investments	-24	-159	-184	-215	-494	-297	-479	-323	-410	-464	-308
Sale and/or Maturity of Investments	33	46	58	79	260	238	475	360	370	446	299
Net Cash From Financing Activities	-19	-6.64	-17	-21	-25	-69	-82	-46	-215	-173	-17
Net Cash From Continuing Financing Activities	-19	-6.64	-17	-21	-25	-69	-82	-46	-215	-173	-17
Repurchase of Common Equity	-	-	-	0.00	-	-53	-50	-22	-197	-163	-9.35
Issuance of Common Equity	2.15	5.02	1.49	4.73	4.91	4.61	3.30	4.92	3.73	4.25	2.71
Other Financing Activities, net	-20	-12	-18	-25	-24	-21	-35	-29	-17	-14	-10
Effect of Exchange Rate Changes	-0.41	-4.02	0.35	-1.70	-1.24	-3.22	3.55	-5.13	3.13	1.80	-6.84
Cash Income Taxes Paid	15	1.45	1.94	6.22	1.02	1.90	1.69	7.39	4.66	3.64	1.01

This table presents UiPath's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Total Assets	866	2,572	2,735	2,955	2,865
Total Current Assets	734	2,277	2,344	2,580	2,339
Cash & Equivalents	358	1,769	1,402	1,062	879
Restricted Cash	7.00	-	0.00	0.44	0.44
Short-Term Investments	103	96	355	818	750
Accounts Receivable	172	252	374	436	451
Prepaid Expenses	50	55	94	105	86
Other Current Assets	45	105	119	159	171
Plant, Property, & Equipment, net	15	17	29	24	33
Total Noncurrent Assets	115	278	362	350	494
Long-Term Investments	-	20	2.94	0.00	94
Goodwill	28	54	88	89	87
Intangible Assets	10	17	23	15	7.91
Noncurrent Deferred & Refundable Income Taxes	8.12	11	5.90	4.68	28
Other Noncurrent Operating Assets	69	177	242	242	277
Total Liabilities & Shareholders' Equity	866	2,572	2,735	2,955	2,865
Total Liabilities	448	651	815	939	1,020
Total Current Liabilities	365	528	626	712	799
Accounts Payable	6.68	12	8.89	3.45	33
Accrued Expenses	37	88	77	84	84
Current Deferred Revenue	211	297	398	487	569
Current Employee Benefit Liabilities	111	131	143	137	112
Total Noncurrent Liabilities	83	123	189	227	221
Noncurrent Deferred Revenue	61	69	122	161	136
Other Noncurrent Operating Liabilities	22	54	67	66	85
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-804	1,922	1,920	2,016	1,846
Total Preferred & Common Equity	-804	1,922	1,920	2,016	1,846
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-804	1,922	1,920	2,016	1,846
Common Stock	179	3,407	3,737	4,024	4,333
Retained Earnings	-970	-1,496	-1,824	-1,914	-1,988
Treasury Stock	-	-	0.00	-103	-495
Accumulated Other Comprehensive Income / (Loss)	-13	11	7.61	8.83	-4.89

This table presents UiPath's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	10/31/2021	4/30/2022	7/31/2022	10/31/2022	4/30/2023	7/31/2023	10/31/2023	4/30/2024	7/31/2024	10/31/2024
Total Assets	2,468	2,425	2,435	2,512	2,643	2,670	2,787	2,845	2,701	2,663
Total Current Assets	2,207	2,145	2,108	2,159	2,257	2,304	2,430	2,469	2,274	2,176
Cash & Equivalents	1,776	1,679	1,607	1,451	1,312	1,094	1,003	1,147	939	774
Restricted Cash	0.00	-	-	-	-	0.40	0.44	0.44	0.44	0.44
Short-Term Investments	102	115	114	226	469	736	814	789	804	795
Accounts Receivable	196	169	193	276	233	226	373	271	268	336
Prepaid Expenses	45	61	63	75	121	107	91	98	85	81
Other Current Assets	88	121	130	132	122	140	148	164	178	190
Plant, Property, & Equipment, net	14	22	26	28	27	25	23	23	22	25
Total Noncurrent Assets	246	258	301	324	358	342	335	353	405	462
Long-Term Investments	13	7.36	2.40	2.92	5.71	0.00	0.00	0.96	-	34
Goodwill	54	52	86	84	89	90	87	88	90	90
Intangible Assets	18	15	27	24	21	19	16	13	11	9.33
Noncurrent Deferred & Refundable Income Taxes	6.85	8.17	8.00	7.66	5.92	5.57	5.14	3.90	3.76	28
Other Noncurrent Operating Assets	153	175	177	206	236	227	226	247	301	300
Total Liabilities & Shareholders' Equity	2,468	2,425	2,435	2,512	2,643	2,670	2,787	2,845	2,701	2,663
Total Liabilities	584	545	585	652	687	687	826	818	868	931
Total Current Liabilities	467	438	460	477	503	518	628	598	633	695
Accounts Payable	24	17	12	11	5.73	1.89	14	6.86	9.91	18
Accrued Expenses	82	76	75	79	63	64	108	85	83	94
Current Deferred Revenue	253	282	292	288	386	384	406	465	463	494
Current Employee Benefit Liabilities	108	63	81	98	49	68	100	41	77	89
Total Noncurrent Liabilities	117	106	125	175	184	169	198	220	235	236
Noncurrent Deferred Revenue	59	57	67	108	113	104	133	151	150	149
Other Noncurrent Operating Liabilities	58	49	58	68	71	65	66	70	85	87
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,883	1,880	1,850	1,860	1,956	1,983	1,961	2,027	1,834	1,732
Total Preferred & Common Equity	1,883	1,880	1,850	1,860	1,956	1,983	1,961	2,027	1,834	1,732
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,883	1,880	1,850	1,860	1,956	1,983	1,961	2,027	1,834	1,732
Common Stock	3,312	3,488	3,577	3,649	3,802	3,888	3,959	4,090	4,177	4,250
Retained Earnings	-1,433	-1,619	-1,739	-1,797	-1,856	-1,917	-1,948	-1,943	-2,029	-2,040
Treasury Stock	-	-	-	-	-	-	-53	-125	-322	-487
Accumulated Other Comprehensive Income / (Loss)	3.83	10	11	6.95	10	12	3.16	4.74	8.11	8.92

This table displays calculated financial ratios and metrics derived from UiPath's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	80.76%	46.84%	18.64%	23.57%	9.30%
EBITDA Growth	0.00%	92.68%	-1,211.96%	41.39%	81.37%	0.19%
EBIT Growth	0.00%	81.71%	-436.93%	32.84%	61.52%	4.08%
NOPAT Growth	0.00%	78.67%	-354.07%	30.47%	52.71%	1.31%
Net Income Growth	0.00%	82.23%	-468.86%	37.53%	72.63%	18.01%
EPS Growth	0.00%	83.87%	-110.91%	48.28%	73.33%	18.75%
Operating Cash Flow Growth	0.00%	108.12%	-288.38%	81.84%	3,096.51%	7.18%
Free Cash Flow Firm Growth	0.00%	0.00%	-1,596.81%	16.48%	75.24%	-9.69%
Invested Capital Growth	0.00%	0.00%	172.56%	330.35%	-15.26%	-10.42%
Revenue Q/Q Growth	0.00%	0.00%	10.10%	1.81%	7.98%	1.30%
EBITDA Q/Q Growth	0.00%	0.00%	-19.38%	5.16%	56.80%	36.08%
EBIT Q/Q Growth	0.00%	0.00%	-17.03%	4.36%	31.54%	14.18%
NOPAT Q/Q Growth	0.00%	0.00%	-15.03%	1.62%	26.78%	10.22%
Net Income Q/Q Growth	0.00%	0.00%	-20.49%	9.74%	40.67%	19.52%
EPS Q/Q Growth	0.00%	0.00%	13.43%	-233.33%	42.86%	13.33%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-78.63%	90.92%	20.87%	0.15%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	15.87%	24.88%	10.34%
Invested Capital Q/Q Growth	0.00%	0.00%	559.93%	-11.00%	-5.39%	-4.90%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	82.33%	89.16%	81.07%	82.99%	85.02%	82.73%
EBITDA Margin	-142.12%	-5.75%	-51.39%	-25.39%	-3.83%	-3.50%
Operating Margin	-153.88%	-18.16%	-56.14%	-32.90%	-12.59%	-11.37%
EBIT Margin	-155.84%	-15.77%	-57.66%	-32.64%	-10.16%	-8.92%
Profit (Net Income) Margin	-154.67%	-15.21%	-58.91%	-31.02%	-6.87%	-5.15%
Tax Burden Percent	100.54%	97.61%	102.88%	103.40%	118.56%	94.36%
Interest Burden Percent	98.71%	98.80%	99.31%	91.91%	57.03%	61.24%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	-246.79%	-77.86%	-88.37%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	-242.15%	-79.26%	-90.60%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	229.70%	73.29%	84.55%
Return on Equity (ROE)	0.00%	-22.09%	-44.92%	-17.09%	-4.57%	-3.82%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-1,179.08%	-371.37%	-61.34%	-77.38%
Operating Return on Assets (OROA)	0.00%	-11.06%	-29.92%	-13.02%	-4.67%	-4.38%
Return on Assets (ROA)	0.00%	-10.66%	-30.57%	-12.37%	-3.16%	-2.53%
Return on Common Equity (ROCE)	0.00%	42.45%	-21.46%	-17.09%	-4.57%	-3.82%
Return on Equity Simple (ROE_SIMPLE)	0.00%	11.50%	-27.35%	-17.10%	-4.46%	-3.99%
Net Operating Profit after Tax (NOPAT)	-362	-77	-351	-244	-115	-114
NOPAT Margin	-107.72%	-12.71%	-39.30%	-23.03%	-8.81%	-7.96%
Net Nonoperating Expense Percent (NNEP)	0.00%	-6.46%	-14.86%	-4.64%	1.40%	2.23%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-12.70%	-5.72%	-6.17%
Cost of Revenue to Revenue	17.67%	10.84%	18.93%	17.01%	14.98%	17.27%
SG&A Expenses to Revenue	53.43%	26.67%	28.02%	22.63%	17.71%	15.82%
R&D to Revenue	38.99%	18.09%	31.01%	26.99%	25.39%	26.63%
Operating Expenses to Revenue	236.21%	107.32%	137.22%	115.89%	97.61%	94.10%
Earnings before Interest and Taxes (EBIT)	-524	-96	-514	-346	-133	-128
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-478	-35	-459	-269	-50	-50
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	9.98	4.42	6.45	4.23
Price to Tangible Book Value (P/TBV)	0.00	0.00	10.36	4.69	6.80	4.46
Price to Revenue (P/Rev)	3.55	1.96	21.50	8.02	9.94	5.47
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	464.43	41.99	81.91	50.05
Enterprise Value to Revenue (EV/Rev)	0.00	3.20	19.39	6.36	8.51	4.26
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	66.70	0.00	0.00	37.21	19.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-1.12	-1.01	-0.95	-0.92	-0.93
Leverage Ratio	0.00	2.07	1.47	1.38	1.45	1.51
Compound Leverage Factor	0.00	2.05	1.46	1.27	0.82	0.92
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	292.15%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-192.15%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	0.88	17.39	6.04	8.46	4.63
Noncontrolling Interest Sharing Ratio	0.00%	292.15%	52.22%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	2.01	4.32	3.74	3.63	2.93
Quick Ratio	0.00	1.73	4.01	3.40	3.25	2.60
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-26	-439	-367	-91	-100
Operating Cash Flow to CapEx	-1,713.15%	913.78%	-464.65%	-41.91%	4,073.58%	2,148.13%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.70	0.52	0.40	0.46	0.49
Accounts Receivable Turnover	0.00	3.53	4.21	3.38	3.23	3.22
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	41.00	55.77	45.81	49.34	50.41
Accounts Payable Turnover	0.00	9.86	18.56	17.65	31.76	13.48
Days Sales Outstanding (DSO)	0.00	103.49	86.78	107.96	113.08	113.28
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	37.03	19.67	20.68	11.49	27.07
Cash Conversion Cycle (CCC)	0.00	66.46	67.11	87.27	101.59	86.21
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	-51	37	160	136	122
Invested Capital Turnover	0.00	-23.67	-126.70	10.72	8.83	11.10
Increase / (Decrease) in Invested Capital	0.00	-51	89	123	-24	-14
Enterprise Value (EV)	0.00	1,946	17,302	6,732	11,128	6,091
Market Capitalization	1,192	1,192	19,187	8,492	13,008	7,815
Book Value per Share	$0.00	($4.78)	$3.66	$3.47	$3.56	$3.36
Tangible Book Value per Share	$0.00	($5.00)	$3.53	$3.27	$3.38	$3.19
Total Capital	0.00	418	1,922	1,920	2,016	1,846
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-468	-1,885	-1,760	-1,880	-1,724
Capital Expenditures (CapEx)	21	3.19	12	24	7.34	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-98	-115	-39	-12	-90
Debt-free Net Working Capital (DFNWC)	0.00	369	1,750	1,718	1,869	1,540
Net Working Capital (NWC)	0.00	369	1,750	1,718	1,869	1,540
Net Nonoperating Expense (NNE)	158	15	175	85	-25	-40
Net Nonoperating Obligations (NNO)	0.00	-470	-1,885	-1,760	-1,880	-1,724
Total Depreciation and Amortization (D&A)	46	61	56	77	83	78
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-16.17%	-12.93%	-3.68%	-0.88%	-6.32%
Debt-free Net Working Capital to Revenue	0.00%	60.77%	196.11%	162.29%	142.86%	107.69%
Net Working Capital to Revenue	0.00%	60.77%	196.11%	162.29%	142.86%	107.69%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($1.16)	($0.60)	($0.16)	($0.13)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	454.63M	548.02M	563.86M	559.93M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($1.16)	($0.60)	($0.16)	($0.13)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	454.63M	548.02M	563.86M	559.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	542.09M	557.42M	569.01M	551.49M
Normalized Net Operating Profit after Tax (NOPAT)	-362	-77	-351	-244	-115	-114
Normalized NOPAT Margin	-107.72%	-12.71%	-39.30%	-23.03%	-8.81%	-7.96%
Pre Tax Income Margin	-153.84%	-15.58%	-57.26%	-30.00%	-5.80%	-5.46%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-24.78%	-0.79%	-0.71%	0.00%	-114.17%	-530.23%

This table displays calculated financial ratios and metrics derived from UiPath's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	23.89%	18.99%	6.51%	18.17%	18.61%	24.05%	31.34%	15.72%	10.07%	8.82%	4.54%
EBITDA Growth	-18.91%	60.48%	38.73%	73.65%	47.77%	42.34%	335.53%	20.04%	-53.29%	35.23%	27.86%
EBIT Growth	-21.96%	45.16%	28.35%	64.54%	41.96%	36.32%	153.64%	7.91%	-36.41%	15.54%	98.59%
NOPAT Growth	-22.87%	42.37%	11.27%	59.97%	35.45%	16.68%	144.27%	-6.58%	-33.21%	22.31%	127.80%
Net Income Growth	-20.35%	52.99%	56.13%	73.97%	49.86%	45.37%	222.49%	9.92%	-42.64%	66.21%	52.71%
EPS Growth	-15.79%	56.52%	-113.51%	73.91%	50.00%	40.00%	240.00%	16.67%	-36.36%	66.67%	28.57%
Operating Cash Flow Growth	-295.55%	-7.44%	1,662.30%	227.34%	286.57%	253.22%	54.97%	48.55%	4.72%	-32.93%	0.33%
Free Cash Flow Firm Growth	-192.61%	-220.91%	-24.53%	20.01%	60.41%	98.93%	124.87%	136.23%	89.38%	-484.99%	19.68%
Invested Capital Growth	5,157.81%	2,324.04%	330.35%	114.52%	22.12%	-20.29%	-15.26%	-46.76%	-41.48%	-10.88%	-10.42%
Revenue Q/Q Growth	-1.16%	8.47%	17.43%	-6.15%	-0.79%	13.44%	24.34%	-17.31%	-5.63%	12.14%	19.45%
EBITDA Q/Q Growth	-2.82%	59.93%	44.28%	-132.05%	-103.80%	55.77%	327.60%	-166.88%	-290.72%	81.31%	549.33%
EBIT Q/Q Growth	-1.71%	45.28%	39.70%	-5.67%	-66.47%	39.96%	150.79%	-281.42%	-146.58%	62.82%	219.42%
NOPAT Q/Q Growth	-3.66%	44.26%	32.61%	-2.80%	-67.17%	28.05%	135.80%	-347.51%	-108.93%	58.04%	204.98%
Net Income Q/Q Growth	1.78%	52.05%	52.03%	-15.21%	-89.21%	47.75%	207.54%	-184.73%	-199.61%	87.62%	586.10%
EPS Q/Q Growth	4.35%	54.55%	50.00%	-20.00%	-83.33%	45.45%	216.67%	-171.43%	-200.00%	86.67%	550.00%
Operating Cash Flow Q/Q Growth	55.12%	-15.08%	443.95%	-28.33%	-34.24%	-5.49%	247.88%	-31.29%	-53.64%	-39.47%	420.42%
Free Cash Flow Firm Q/Q Growth	-35.07%	-13.40%	34.22%	20.60%	33.15%	96.93%	1,627.20%	15.68%	-119.59%	-69.03%	412.44%
Invested Capital Q/Q Growth	59.27%	43.42%	-11.00%	5.52%	-9.33%	-6.39%	-5.39%	-33.70%	-0.33%	42.55%	-4.90%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	81.60%	83.72%	84.54%	84.92%	82.95%	84.68%	86.84%	83.49%	79.98%	82.02%	84.77%
EBITDA Margin	-42.73%	-15.78%	-7.49%	-9.16%	-18.82%	-7.34%	13.43%	-6.33%	-26.20%	-4.37%	16.43%
Operating Margin	-49.62%	-25.50%	-14.63%	-16.03%	-27.00%	-17.13%	3.72%	-14.76%	-32.68%	-12.23%	7.93%
EBIT Margin	-49.87%	-25.16%	-12.92%	-14.54%	-24.40%	-12.92%	5.28%	-11.57%	-30.24%	-10.03%	10.02%
Profit (Net Income) Margin	-49.70%	-21.97%	-8.97%	-11.02%	-21.01%	-9.68%	8.37%	-8.58%	-27.22%	-3.00%	12.23%
Tax Burden Percent	103.52%	102.09%	102.71%	112.85%	106.78%	114.22%	92.68%	115.15%	104.65%	41.79%	94.82%
Interest Burden Percent	96.27%	85.54%	67.64%	67.12%	80.63%	65.59%	171.18%	64.34%	86.02%	71.72%	128.66%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.32%	0.00%	0.00%	0.00%	5.18%
Return on Invested Capital (ROIC)	-541.55%	-215.72%	-109.75%	-99.78%	-155.58%	-89.72%	30.49%	-107.90%	-260.12%	-88.96%	83.51%
ROIC Less NNEP Spread (ROIC-NNEP)	-539.54%	-215.11%	-109.97%	-99.82%	-155.24%	-90.15%	29.40%	-108.21%	-259.35%	-90.11%	82.41%
Return on Net Nonoperating Assets (RNNOA)	521.12%	205.22%	104.31%	93.36%	143.94%	82.51%	-27.19%	101.17%	242.83%	83.49%	-76.91%
Return on Equity (ROE)	-20.43%	-10.49%	-5.44%	-6.42%	-11.64%	-7.21%	3.31%	-6.73%	-17.29%	-5.47%	6.60%
Cash Return on Invested Capital (CROIC)	-633.62%	-242.06%	-371.37%	-230.15%	-138.41%	-74.70%	-61.34%	-29.57%	-59.09%	-81.85%	-77.38%
Operating Return on Assets (OROA)	-20.81%	-10.51%	-5.15%	-6.33%	-10.98%	-5.91%	2.43%	-5.71%	-15.57%	-5.19%	4.92%
Return on Assets (ROA)	-20.74%	-9.17%	-3.58%	-4.80%	-9.45%	-4.42%	3.85%	-4.23%	-14.01%	-1.56%	6.01%
Return on Common Equity (ROCE)	-20.43%	-10.49%	-5.44%	-6.42%	-11.64%	-7.21%	3.31%	-6.73%	-17.29%	-5.47%	6.60%
Return on Equity Simple (ROE_SIMPLE)	-23.19%	-19.56%	0.00%	-12.15%	-8.96%	-7.72%	0.00%	-4.28%	-6.13%	-5.29%	0.00%
Net Operating Profit after Tax (NOPAT)	-84	-47	-32	-32	-54	-39	14	-35	-72	-30	32
NOPAT Margin	-34.73%	-17.85%	-10.24%	-11.22%	-18.90%	-11.99%	3.45%	-10.33%	-22.88%	-8.56%	7.52%
Net Nonoperating Expense Percent (NNEP)	-2.00%	-0.61%	0.21%	0.03%	-0.34%	0.43%	1.09%	0.32%	-0.77%	1.15%	1.11%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-1.65%	-	-	-	0.69%	-	-	-	1.73%
Cost of Revenue to Revenue	18.40%	16.28%	15.46%	15.08%	17.05%	15.32%	13.16%	16.51%	20.02%	17.98%	15.23%
SG&A Expenses to Revenue	28.26%	24.04%	16.33%	19.54%	20.74%	17.19%	14.67%	18.95%	20.08%	14.12%	11.57%
R&D to Revenue	28.01%	25.63%	26.53%	26.02%	30.14%	25.93%	21.13%	25.54%	31.12%	27.34%	23.53%
Operating Expenses to Revenue	131.22%	109.22%	99.18%	100.95%	109.95%	101.81%	83.11%	98.25%	112.66%	94.25%	76.83%
Earnings before Interest and Taxes (EBIT)	-121	-66	-40	-42	-70	-42	21	-39	-96	-36	42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-104	-41	-23	-27	-54	-24	54	-21	-83	-15	70
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.40	3.74	4.42	4.01	5.12	4.49	6.45	5.33	3.80	3.93	4.23
Price to Tangible Book Value (P/TBV)	5.75	3.97	4.69	4.25	5.41	4.74	6.80	5.60	4.02	4.16	4.46
Price to Revenue (P/Rev)	10.01	6.69	8.02	7.11	8.84	7.27	9.94	7.97	5.04	4.82	5.47
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	65.77	29.27	41.99	35.83	54.21	48.64	81.91	98.34	58.23	40.58	50.05
Enterprise Value to Revenue (EV/Rev)	8.28	5.07	6.36	5.50	7.24	5.77	8.51	6.54	3.78	3.68	4.26
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	54.99	46.65	28.22	37.21	26.70	15.66	16.23	19.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.97	-0.95	-0.95	-0.94	-0.93	-0.92	-0.92	-0.93	-0.94	-0.93	-0.93
Leverage Ratio	1.28	1.33	1.38	1.32	1.33	1.39	1.45	1.38	1.41	1.48	1.51
Compound Leverage Factor	1.23	1.14	0.93	0.89	1.07	0.91	2.47	0.89	1.21	1.06	1.94
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	10.30	6.53	6.41	7.03	9.00	6.58	8.63	8.18	4.89	4.46	4.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.58	4.53	3.74	4.48	4.45	3.87	3.63	4.13	3.60	3.13	2.93
Quick Ratio	4.16	4.10	3.40	4.00	3.97	3.49	3.25	3.69	3.18	2.74	2.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-207	-235	-155	-123	-82	-2.52	38	44	-8.72	-15	46
Operating Cash Flow to CapEx	-359.32%	-513.86%	4,268.83%	3,601.12%	4,402.09%	6,136.95%	3,847.83%	8,080.53%	3,270.52%	575.79%	1,976.22%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.42	0.42	0.40	0.44	0.45	0.46	0.46	0.49	0.51	0.52	0.49
Accounts Receivable Turnover	6.00	4.40	3.38	5.48	5.47	3.73	3.23	5.37	5.60	3.98	3.22
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	49.59	49.11	45.81	45.31	45.75	47.83	49.34	54.52	59.19	59.25	50.41
Accounts Payable Turnover	23.19	9.86	17.65	15.42	26.14	15.27	31.76	32.95	37.62	14.69	13.48
Days Sales Outstanding (DSO)	60.80	82.91	107.96	66.57	66.73	97.78	113.08	67.94	65.21	91.71	113.28
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	15.74	37.02	20.68	23.67	13.96	23.90	11.49	11.08	9.70	24.84	27.07
Cash Conversion Cycle (CCC)	45.06	45.90	87.27	42.90	52.76	73.88	101.59	56.87	55.51	66.87	86.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	126	180	160	169	153	144	136	90	90	128	122
Invested Capital Turnover	15.59	12.09	10.72	8.89	8.23	7.48	8.83	10.44	11.37	10.39	11.10
Increase / (Decrease) in Invested Capital	123	188	123	90	28	-37	-24	-79	-64	-16	-14
Enterprise Value (EV)	8,261	5,273	6,732	6,062	8,316	6,984	11,128	8,857	5,227	5,194	6,091
Market Capitalization	9,985	6,953	8,492	7,849	10,146	8,801	13,008	10,794	6,971	6,797	7,815
Book Value per Share	$3.40	$3.38	$3.47	$3.51	$3.53	$3.46	$3.56	$3.56	$3.20	$3.15	$3.36
Tangible Book Value per Share	$3.19	$3.19	$3.27	$3.31	$3.34	$3.28	$3.38	$3.38	$3.03	$2.97	$3.19
Total Capital	1,850	1,860	1,920	1,956	1,983	1,961	2,016	2,027	1,834	1,732	1,846
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-1,724	-1,680	-1,760	-1,786	-1,830	-1,818	-1,880	-1,937	-1,744	-1,604	-1,724
Capital Expenditures (CapEx)	6.61	5.32	2.20	1.87	1.01	0.68	3.78	1.24	1.42	4.88	7.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-73	5.85	-39	-27	-45	-16	-12	-64	-102	-88	-90
Debt-free Net Working Capital (DFNWC)	1,648	1,683	1,718	1,754	1,785	1,802	1,869	1,872	1,642	1,481	1,540
Net Working Capital (NWC)	1,648	1,683	1,718	1,754	1,785	1,802	1,869	1,872	1,642	1,481	1,540
Net Nonoperating Expense (NNE)	36	11	-3.91	-0.59	6.05	-7.54	-20	-5.89	14	-20	-20
Net Nonoperating Obligations (NNO)	-1,724	-1,680	-1,760	-1,786	-1,830	-1,818	-1,880	-1,937	-1,744	-1,604	-1,724
Total Depreciation and Amortization (D&A)	17	25	17	16	16	18	33	18	13	20	27
Debt-free, Cash-free Net Working Capital to Revenue	-7.33%	0.56%	-3.68%	-2.43%	-3.88%	-1.29%	-0.88%	-4.75%	-7.38%	-6.27%	-6.32%
Debt-free Net Working Capital to Revenue	165.20%	161.83%	162.29%	159.00%	155.50%	148.75%	142.86%	138.27%	118.75%	104.94%	107.69%
Net Working Capital to Revenue	165.20%	161.83%	162.29%	159.00%	155.50%	148.75%	142.86%	138.27%	118.75%	104.94%	107.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.22)	($0.10)	($0.05)	($0.06)	($0.11)	($0.06)	$0.07	($0.05)	($0.15)	($0.02)	$0.09
Adjusted Weighted Average Basic Shares Outstanding	546.06M	550.16M	548.02M	557.88M	562.88M	567.04M	563.86M	569.93M	568.04M	551.04M	559.93M
Adjusted Diluted Earnings per Share	($0.22)	($0.10)	($0.05)	($0.06)	($0.11)	($0.06)	$0.07	($0.05)	($0.15)	($0.02)	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	546.06M	550.16M	548.02M	557.88M	562.88M	567.04M	563.86M	569.93M	568.04M	551.04M	559.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	549.61M	552.84M	557.42M	561.16M	566.74M	566.08M	569.01M	572.78M	549.96M	549.60M	551.49M
Normalized Net Operating Profit after Tax (NOPAT)	-84	-47	-32	-32	-54	-39	14	-35	-72	-30	32
Normalized NOPAT Margin	-34.73%	-17.85%	-10.24%	-11.22%	-18.90%	-11.99%	3.45%	-10.33%	-22.88%	-8.56%	7.52%
Pre Tax Income Margin	-48.01%	-21.52%	-8.74%	-9.76%	-19.68%	-8.47%	9.03%	-7.45%	-26.01%	-7.19%	12.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-34.75%	-114.17%	-143.71%	-285.78%	-471.07%	-530.23%

Financials Breakdown Chart

Key Financial Trends

UiPath (NYSE: PATH) Financial Summary and Trends (Q3 2022 to Q4 2025)

Analyzing UiPath’s last four years of quarterly financial statements reveals a company experiencing fluctuating profitability, improving cash flow generation, substantial operating expenses, and healthy liquidity. Here are the key highlights and trends impacting UiPath:

Revenue Growth:
Operating revenue has grown steadily from $220.8 million in Q3 2022 to $423.6 million in Q4 2025, nearly doubling in that period, demonstrating strong top-line growth.
Gross Profit Consistency:
Gross profit margins have generally remained robust, with gross profit rising from approximately $177.7 million in Q3 2022 to $359.1 million in Q4 2025, indicating effective cost control on revenue.
Cash Flow from Operations Improvement:
Net cash provided by operating activities improved dramatically from negative territory in early 2023 (e.g., -$52.8 million in Q1 2023) to a positive $146.1 million in Q4 2025, reflecting better operating efficiency and cash discipline.
Strong Cash, Equivalents, and Short-term Investments Balance:
UiPath has maintained a substantial liquidity position, with cash and equivalents plus short-term investments often exceeding $1.5 billion through 2024 and into 2025, supporting flexibility for investment and operations.
Operating Expenses Are High and Growing:
Marketing, sales, general & admin, and R&D expenses cumulatively reach over $325 million in Q4 2025, indicating continued heavy investment in growth initiatives, though this weighs on profitability.
Net Income Volatility:
UiPath exhibited net losses through much of 2023 and 2024, with occasional positive net income quarters starting Q4 2024, and turning net profitable in Q4 2025 ($51.8 million). This suggests a transition phase balancing growth against profitability.
Stable Shares Outstanding:
The weighted average diluted shares outstanding have remained relatively steady around 540-560 million shares, with minor fluctuations, indicating controlled dilution.
Large Quarterly Operating Losses in Previous Years:
Significant net losses such as -$120.4 million in Q2 2023 and -$115.9 million in Q1 2023 highlight historical challenges in reaching profitability.
Negative Operating Income in Most Quarters Prior to 2025:
Most quarters through 2023 and 2024 recorded negative operating income, underscoring the pressure from high operating expenses relative to revenue.
Significant Capital Used in Investing Activities:
Net cash used in investing activities on occasion reached high levels (e.g., -$235 million in Q2 2024, -$287 million in Q2 2023). This may impact cash reserves long-term if not balanced by operating inflows.

Summary: UiPath is progressively improving its financial health, showing solid revenue growth and improving cash flow generation. The company is still in transition to sustained profitability with high operating expenses impacting earnings until late 2024, but profitable results in late 2025 suggest positive momentum. Maintaining high liquidity and managing investments will be key for ongoing growth and profitability stability.

10/24/25 05:58 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About UiPath's Financials

When does UiPath's financial year end?

According to the most recent income statement we have on file, UiPath's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

How has UiPath's net income changed over the last 5 years?

UiPath's net income appears to be on a downward trend, with a most recent value of -$73.69 million in 2025, falling from -$519.93 million in 2020. The previous period was -$89.88 million in 2024. Check out UiPath's forecast to explore projected trends and price targets.

What is UiPath's operating income?

UiPath's total operating income in 2025 was -$162.57 million, based on the following breakdown:

Total Gross Profit: $1.18 billion
Total Operating Expenses: $1.35 billion

How has UiPath's revenue changed over the last 5 years?

Over the last 5 years, UiPath's total revenue changed from $336.16 million in 2020 to $1.43 billion in 2025, a change of 325.3%.

How much debt does UiPath have?

UiPath's total liabilities were at $1.02 billion at the end of 2025, a 8.6% increase from 2024, and a 127.5% increase since 2021.

How much cash does UiPath have?

In the past 4 years, UiPath's cash and equivalents has ranged from $357.69 million in 2021 to $1.77 billion in 2022, and is currently $879.20 million as of their latest financial filing in 2025.

How has UiPath's book value per share changed over the last 5 years?

Over the last 5 years, UiPath's book value per share changed from 0.00 in 2020 to 3.36 in 2025, a change of 335.8%.

Related Companies

This page (NYSE:PATH) was last updated on 10/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UiPath (PATH) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About UiPath's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UiPath (PATH) Financials

Annual Income Statements for UiPath

Quarterly Income Statements for UiPath

Annual Cash Flow Statements for UiPath

Quarterly Cash Flow Statements for UiPath

Annual Balance Sheets for UiPath

Quarterly Balance Sheets for UiPath

Annual Metrics And Ratios for UiPath

Quarterly Metrics And Ratios for UiPath

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About UiPath's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools